Skip to content
10-Q

Quarterly Report

Rain Oncology Inc.

0001558370-23-009375

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 4, 2023 36.36M sh
Shares Diluted Q1 2023 · Mar 31, 2023 36.34M sh
Shares Diluted Q1 2023 · Mar 31, 2022 26.51M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$21.84M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$17.11M
Short Term Investments Q1 2023 · Mar 31, 2023 $65.67M
Short Term Investments Q1 2023 · Dec 31, 2022 $68.5M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $44.1M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $61.96M
Stockholders Equity Q1 2023 · Mar 31, 2023 $94.56M
Stockholders Equity Q1 2023 · Dec 31, 2022 $113.04M
Stockholders Equity Q1 2023 · Mar 31, 2022 $114.45M
Stockholders Equity Q1 2023 · Dec 31, 2021 $130.5M
Current Liabilities Q1 2023 · Mar 31, 2023 $19.48M
Current Liabilities Q1 2023 · Dec 31, 2022 $21.97M
Total Liabilities Q1 2023 · Mar 31, 2023 $19.62M
Total Liabilities Q1 2023 · Dec 31, 2022 $22.14M
Current Assets Q1 2023 · Mar 31, 2023 $112.98M
Current Assets Q1 2023 · Dec 31, 2022 $133.63M
Total Assets Q1 2023 · Mar 31, 2023 $114.18M
Total Assets Q1 2023 · Dec 31, 2022 $135.18M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.56
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.66
Eps Basic Q1 2023 · Mar 31, 2023 −$0.56
Eps Basic Q1 2023 · Mar 31, 2022 −$0.66
Sga Expense Q1 2023 · Mar 31, 2023 $5.07M
Sga Expense Q1 2023 · Mar 31, 2022 $3.9M
Rd Expense Q1 2023 · Mar 31, 2023 $16.68M
Rd Expense Q1 2023 · Mar 31, 2022 $13.56M
Net Income Q1 2023 · Mar 31, 2023 −$20.48M
Net Income Q1 2023 · Mar 31, 2022 −$17.39M
Operating Income Q1 2023 · Mar 31, 2023 −$21.74M
Operating Income Q1 2023 · Mar 31, 2022 −$17.45M